Gene · 18
Papers2,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,776
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study. | Children (Basel) | 2023 | 38002866 | PubTator, text mining | PubMed |
| Exploring the potential mechanism of Kaixinsan powder for the same pathogenesis of PTSD and anxiety based on network pharmacology and molecular docking: A review. | Medicine (Baltimore) | 2023 | 37986356 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development. | World J Gastrointest Oncol | 2023 | 37969406 | PubTator, text mining | PubMed |
| Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas. | PLoS One | 2023 | 37967105 | PubTator, text mining | PubMed |
| Gene expression analyses reveal differences in children's response to malaria according to their age. | bioRxiv | 2023 | 37961701 | PubTator, text mining | PubMed |
| Gene expression analyses reveal differences in children's response to malaria according to their age. | Res Sq | 2023 | 37961587 | PubTator, text mining | PubMed |
| The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation. | Sci Rep | 2023 | 37945610 | PubTator, text mining | PubMed |
| Vigabatrin (Sabril) for the Treatment of Refractory Complex Focal Seizures in Adults: Pharmacologic and Clinical Considerations. | Cureus | 2023 | 37927747 | PubTator, text mining | PubMed |
The possible "calming effect" of subchronic supplementation of a standardised phospholipid carrier-based Melissa officinalis L. extract in healthy adults with emotional distress and poor sleep conditions: results from a prospective, randomised, double-blinded, placebo-controlled clinical trial. | Front Pharmacol | 2023 | 37927585 | PubTator, text mining | PubMed |
| Tumor-Promoting Effects of Microrna-421/4-Aminobutyrate Aminotransferase Axis in Hepatocellular Carcinoma. | Rev Invest Clin | 2023 | 37918014 | PubTator, text mining | PubMed |
| Real-time resolution studies of the regulation of pyruvate-dependent lactate metabolism by hexokinases in single cells. | PLoS One | 2023 | 37917627 | PubTator, text mining | PubMed |
| Tumor Microbial Communities and Thyroid Cancer Development-The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions. | Antioxidants (Basel) | 2023 | 37891977 | PubTator, text mining | PubMed |
| Mitochondrial subtype MB-G3 contains potential novel biomarkers and therapeutic targets associated with prognosis of medulloblastoma. | Biomarkers | 2023 | 37886818 | PubTator, text mining | PubMed |
| The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time? | J Cent Nerv Syst Dis | 2023 | 37868934 | PubTator, text mining | PubMed |
| Photoinduced Efficient Catalytic α-Alkylation Reactions of Active Methylene and Methine Compounds with Nonactivated Alkenes. | J Am Chem Soc | 2023 | 37846890 | PubTator, text mining | PubMed |
| A Case of Vigabatrin Toxicity Mimicking Bilateral Thalamic Infarcts on MRI. | Cureus | 2023 | 37829947 | PubTator, text mining | PubMed |
| Treatment of startle and related disorders. | Clin Park Relat Disord | 2023 | 37808566 | PubTator, text mining | PubMed |
| Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer. | Front Cell Dev Biol | 2023 | 37808079 | PubTator, text mining | PubMed |
| Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin. | Front Neurosci | 2023 | 37790589 | PubTator, text mining | PubMed |
| Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related HCC. | Hepatol Commun | 2023 | 37782459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/18/papers?page=6